Skip Nav Destination
Close Modal
1-20 of 422 Search Results for
biomedical
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
1
Journal Article
J Health Polit Policy Law (2001) 26 (6): 1412–1415.
Published: 01 December 2001
....
374 pp. $55.00 cloth; $22.50 paper.
Ethical Issues in Biomedical Publication offers a multitude of excellent
examples of how Catch 22 operates in modern academia. It could (and
perhaps should) serve as the textbook for a mandatory course on ethical...
Journal Article
J Health Polit Policy Law (2016) 41 (5): 917–937.
Published: 01 October 2016
...Karen J. Maschke; Michael K. Gusmano Abstract The controversy over patients’ access to stem cell interventions is familiar to scholars of the drug regulatory system and the politics of evidence-based medicine. What counts as evidence of a biomedical intervention's safety and effectiveness? Who...
Journal Article
J Health Polit Policy Law (1987) 12 (3): 582–584.
Published: 01 June 1987
...Richard A. Rettig Victoria A. Harden, Inventing the NIH: Federal Biomedical Research Policy, 1887–1937 (Baltimore: Johns Hopkins University Press, 1986), 274 pp. Copyright © 1987 by Duke University Press 1987 582 Journal of Health Politics, PoIicy and Law
iation on the “dance...
Journal Article
J Health Polit Policy Law (1998) 23 (1): 175–193.
Published: 01 February 1998
...Nancy R. Aries; Elliott D. Sclar This study estimates the economic significance of biomedical research for a geographic region. Through a survey of nonprofit biomedical research institutions in the metropolitan New York region and an analysis of research budget data obtained from the area’s six...
Journal Article
J Health Polit Policy Law (1984) 9 (1): 63–80.
Published: 01 February 1984
... equally critical, do not). The issue of federal support for research on aging, which led to a specific demand for a separate institute, was initiated by a small group of biomedical scientists. But it reached agenda status only after an effective coalition of lay and professional groups gave support...
Journal Article
J Health Polit Policy Law (1994) 19 (4): 773–799.
Published: 01 August 1994
... increasingly to a new positivist discipline, called health services research, for which neoclassical health economics is the dominant discourse. However this discipline may actually reinforce the strength of biomedical positivism and the concomitant technological imperative. Like biomedicine, health services...
Journal Article
J Health Polit Policy Law (2016) 41 (4): 521–539.
Published: 01 August 2016
... the late nineteenth through the mid-twentieth centuries to implement diagnostic systems based on the principle of specificity, psychiatric diagnoses remained undifferentiated, overlapping, and capacious. The need for medical legitimacy, compatibility with a biomedical model, and conditions that third...
Journal Article
J Health Polit Policy Law (2011) 36 (1): 119–139.
Published: 01 February 2011
...Bhaven Sampat; Michael Drummond Confronted with similar challenges, the United States and the United Kingdom have adopted very different health technology policies. In the United States, the focus has been on technology creation, in particular the funding of basic biomedical research...
Journal Article
J Health Polit Policy Law (1985) 10 (3): 549–564.
Published: 01 June 1985
.... If they are to take part in allocation decisions, for the continued well-being of their patients and of the public health, they will need a new perspective on biomedical ethics. This role can be an ethical one for physicians providing certain criteria are met: (1) there must be universal access to a basic minimum...
Journal Article
J Health Polit Policy Law (2016) 41 (4): 599–626.
Published: 01 August 2016
... crucified, dead, and buried by the rise of modern biomedicine from the mid-nineteenth century through the mid-twentieth century. Problems and lacunae in purely biomedical approaches to health in the later twentieth century, along with developments of new biopsychosocial approaches to health, have spawned...
FIGURES
| View All (11)
Journal Article
J Health Polit Policy Law (2000) 25 (5): 988–991.
Published: 01 October 2000
... of the government’s entire civilian research expenditure. NIH’s almost
totemic status in Congress is wonderful news for biomedical researchers,
for the biomedical industry that depends on federal research for contin-
ued innovation, and for those who hold stock in biotechnology corpora-
tions. But what does...
Journal Article
J Health Polit Policy Law (2011) 36 (5): 900–904.
Published: 01 October 2011
.... . 2001 . Principles of Biomedical Ethics . 5th ed. New York : Oxford University Press . Bush G. W. 2001a . Executive Order 13237: Creation of the President's Council on Bioethics . November 28 . bioethics.georgetown.edu/pcbe/about/executive.html . ———. 2001b . Text: President...
Journal Article
J Health Polit Policy Law (2011) 36 (5): 897–900.
Published: 01 October 2011
...
“all of the medical and ethical ramifications of biomedical innovation” (2).
At the time, concern applied chiefly to the field of stem cell research — the
subject of the president’s speech — and the related topic of human cloning,
both frequent fodder for headlines everywhere, from the New...
Journal Article
J Health Polit Policy Law (2017) 42 (2): 413–417.
Published: 01 April 2017
... syndrome has emerged across disciplines in the biomedical and health sciences as a loosely defined set of statistical risk factors that purport to predict heart disease, diabetes, and other poor health outcomes (Hatch 2016). While there remains little consensus over how to define metabolic syndrome...
Journal Article
J Health Polit Policy Law (1999) 24 (1): 181–196.
Published: 01 February 1999
... least, in lay discourse one does not cause the
other. In biomedical language, the question itself is altogether unintelli-
gible. Illness is an inexact lay term, resting upon unreliable subjective
experiences and belief, something to be discarded in favor of the scien-
tific study and treatment...
Journal Article
J Health Polit Policy Law (2016) 41 (5): 869–871.
Published: 01 October 2016
... with this dilemma, Karen Maschke and Michael Gusmano rightly argue that one must first ask: What counts as evidence for a biomedical intervention? Who should define appropriate assessment, safety, and effectiveness, and how? To address these questions, they review several proposed initiatives to get stem cell...
Journal Article
J Health Polit Policy Law (1996) 21 (4): 871–880.
Published: 01 August 1996
...
findings” that question much of the past century’s received wisdom
regarding health science and policy, and to provide a new synthesis or
paradigm that overcomes the limitations of existing ones. The conven-
tional model they want to supersede is the descendant of Panakaia—the
biomedical perspective...
Journal Article
J Health Polit Policy Law (2000) 25 (3): 447–450.
Published: 01 June 2000
..., they bear explicit scrutiny in health
policy circles because of the history of how they have been addressed (or
not) in biomedical research and by providers. One need not be a feminist
theorist or ignore the potential non–gender specific generalizations about...
Journal Article
J Health Polit Policy Law (1984) 9 (1): 167–173.
Published: 01 February 1984
... as the principal
focus for biomedical research. But the basic question one must raise about The
Sick Citadel is whether the role it advocates for the AMC is even remotely
feasible in the current climate of financial restraint. The book envisages AMCs
guaranteeing health care for all...
Journal Article
J Health Polit Policy Law (1991) 16 (3): 595–604.
Published: 01 June 1991
... by the many elements of the social order and
often independent from biomedical phenomena. In this perspective, medical
sociology links together and makes sense of the varied manifestationsof health
and illness: biomedical data, professional practice, institutional structures,
I am grateful...
1
